Zobrazeno 1 - 10
of 87
pro vyhledávání: '"Ayodeji A Asuni"'
Autor:
Song Guo, Rikke Holm Rasmussen, Anders Hay-Schmidt, Messoud Ashina, Ayodeji A. Asuni, Jeppe Møller Jensen, Anja Holm, Sabrina Prehn Lauritzen, Glenn Dorsam, Jens Hannibal, Birgitte Georg, David Møbjerg Kristensen, Jes Olesen, Sarah Louise Christensen
Publikováno v:
The Journal of Headache and Pain, Vol 25, Iss 1, Pp 1-12 (2024)
Abstract Background Pituitary adenylate cyclase-activating peptide (PACAP) is a neuropeptide pivotal in migraine pathophysiology and is considered a promising new migraine drug target. Although intravenous PACAP triggers migraine attacks and a recent
Externí odkaz:
https://doaj.org/article/1b5638b4204d4c57a3832603fc0281f0
Publikováno v:
Frontiers in Aging Neuroscience, Vol 12 (2020)
Alzheimer’s disease (AD) is the most common form of dementia worldwide. It is mostly known for its devastating effect on memory and learning but behavioral alterations commonly known as neuropsychiatric disturbances (NPDs) are also characteristics
Externí odkaz:
https://doaj.org/article/bd87197fd2814955a66fff29d17dff15
Publikováno v:
Frontiers in Neuroscience, Vol 12 (2018)
There are nearly 50 million people with Alzheimer's disease (AD) worldwide and currently no disease modifying treatment is available. AD is characterized by deposits of Amyloid-β (Aβ), neurofibrillary tangles, and neuroinflammation, and several dru
Externí odkaz:
https://doaj.org/article/ec3416e15b894065b1b232b413dac31a
Autor:
Thomas E, Wuensche, Natascha, Stergiou, Iris, Mes, Mariska, Verlaan, Maxime, Schreurs, Esther J M, Kooijman, Bart, Janssen, Albert D, Windhorst, Allan, Jensen, Ayodeji A, Asuni, Benny, Bang-Andersen, Wissam, Beaino, Guus A M S, Dongen, Danielle J, Vugts
Publikováno v:
Theranostics. 12(16)
The accelerated approval of the monoclonal antibody (mAb) aducanumab as a treatment option for Alzheimer's Disease and the continued discussions about its efficacy have shown that a better understanding of immunotherapy for the treatment of neurodege
Autor:
Allan Stensballe, Kenneth Kastaniegaard, Christiane Volbracht, Joakim Bastrup, Ayodeji A. Asuni
Publikováno v:
Bastrup, J, Kastaniegaard, K, Asuni, A A, Volbracht, C & Stensballe, A 2020, ' Proteomic and Unbiased Post-Translational Modification Profiling of Amyloid Plaques and Surrounding Tissue in a Transgenic Mouse Model of Alzheimer's Disease ', Journal of Alzheimer's Disease, vol. 73, no. 1, pp. 393-411 . https://doi.org/10.3233/JAD-190652
Amyloid plaques are one of the hallmarks of Alzheimer's disease (AD). The main constituent of amyloid plaques is amyloid-β peptides, but a complex interplay of other infiltrating proteins also co-localizes. We hypothesized that proteomic analysis co
Autor:
Amalie Clement, Marianne Juul Madsen, Kenneth Kastaniegaard, Ove Wiborg, Ayodeji A. Asuni, Allan Stensballe
Publikováno v:
Clement, A, Madsen, M J, Kastaniegaard, K, Wiborg, O, Asuni, A A & Stensballe, A 2022, ' Chronic Stress Induces Hippocampal Mitochondrial Damage in APPPS1 Model Mice and Wildtype Littermates ', Journal of Alzheimer's Disease, vol. 87, no. 1, pp. 259-272 . https://doi.org/10.3233/JAD-220064
BACKGROUND: Alzheimer's disease (AD) is a neurodegenerative disorder and the most common cause of dementia worldwide. Despite decades of investigation, the etiology of AD is not fully understood, although emerging evidence suggest that chronic enviro
Autor:
Thomas E. Wuensche, Natascha Stergiou, Iris Mes, Mariska Verlaan, Maxime Schreurs, Esther J. M. Kooijman, Bart Janssen, Albert D. Windhorst, Allan Jensen, Ayodeji A. Asuni, Benny Bang-Andersen, Wissam Beaino, Guus A. M. S. Dongen, Danielle J. Vugts
Publikováno v:
Theranostics, 12(16), 7067-7079. Ivyspring International Publisher
Wuensche, T E, Stergiou, N, Mes, I, Verlaan, M, Schreurs, M, Kooijman, E J M, Janssen, B, Windhorst, A D, Jensen, A, Asuni, A A, Bang-Andersen, B, van Dongen, G A M S, Beaino, W & Vugts, D J 2022, ' Advancing 89Zr-immuno-PET in neuroscience with a bispecific anti-amyloid-beta monoclonal antibody – the choice of chelator is essential ', Theranostics, vol. 12, no. 16, pp. 7067-7079 . https://doi.org/10.7150/thno.73509
Wuensche, T E, Stergiou, N, Mes, I, Verlaan, M, Schreurs, M, Kooijman, E J M, Janssen, B, Windhorst, A D, Jensen, A, Asuni, A A, Bang-Andersen, B, van Dongen, G A M S, Beaino, W & Vugts, D J 2022, ' Advancing 89Zr-immuno-PET in neuroscience with a bispecific anti-amyloid-beta monoclonal antibody – the choice of chelator is essential ', Theranostics, vol. 12, no. 16, pp. 7067-7079 . https://doi.org/10.7150/thno.73509
The accelerated approval of the monoclonal antibody (mAb) aducanumab as a treatment option for Alzheimer’s Disease and the continued discussions about its efficacy have shown that a better understanding of immunotherapy for the treatment of neurode
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ad4d3375c16493f62b237d91b0a1ba2a
https://research.vumc.nl/en/publications/b7328b80-aecb-4811-90b2-07640111d96c
https://research.vumc.nl/en/publications/b7328b80-aecb-4811-90b2-07640111d96c
Autor:
Natascha Stergiou, Thomas Wünsche, Iris Mes, Maxime Schreurs, Mariska Verlaan, Esther Kooijman, Albert D. Windhorst, Guus AMS Dongen, Lone Helboe, Sandra Vergo, Søren Christensen, Ayodeji A Asuni, Allan Jensen, Benny Bang‐Andersen, Danielle Vugts, Wissam Beaino
Publikováno v:
Alzheimer's & Dementia. 17
Publikováno v:
Clement, A, Pedersen, M M, Stensballe, A, Wiborg, O & Asuni, A A 2021, ' Chronic stress induces NPD-like behavior in APPPS1 and WT mice with subtle differences in gene expression ', Genes, Brain and Behavior, vol. 20, no. 8, e12766 . https://doi.org/10.1111/gbb.12766
Neuropsychiatric disturbances (NPDs) are considered hallmarks of Alzheimer's disease (AD). Nevertheless, treatment of these symptoms has proven difficult and development of safe and effective treatment options is hampered by the limited understanding
Autor:
G. A. M. S. Dongen, Esther J.M. Kooijman, E. T. Wünsche, Lone Helboe, Ayodeji A. Asuni, Soren Christensen, Wissam Beaino, Albert D. Windhorst, Benny Bang-Andersen, Mariska Verlaan, D.J. Vugts, Maxime Schreurs, I. Mes, N. Stergiou, S. Vergo, Anders A. Jensen
Publikováno v:
Nuclear Medicine and Biology.